The effect of clonazepam to reduce anxiety
Phase 3
- Conditions
- Anxiety.Phobic anxiety disorders
- Registration Number
- IRCT201012195420N1
- Lead Sponsor
- Vice chancellor for research of Shiraz University of Medical Sciences and Health Services
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Inclusion Criteria: patients referred to the Department of Surgery, Shiraz Dental School.
Exclusion Criteria
children and people under 18; addicts; smoking; all systemic diseases; women during menstruation; and all drugs consumers.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Anxiety. Timepoint: 1 hour. Method of measurement: Visual Analogue Scale.;Blood pressure. Timepoint: 1 hour. Method of measurement: mm HG by using a Digital Manometer.;Pulse rate. Timepoint: 1 hour. Method of measurement: number per minutes by Digital Pulse Oximetry.;Oxygen saturation of blood. Timepoint: 1 hour. Method of measurement: percent by Digital Pulse Oximetry.
- Secondary Outcome Measures
Name Time Method